Company Summary
Search
Home Page
 
*InNexus Biotechnology Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
June 30DelistN
Board of Directors
NamePosition
(not available)
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
5/Sep/1997 2/Oct/2013 Canada British Columbia  
Exchange Filing Office
Location
(not available)
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  *Biotechnology Research &/or Development  InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking technology (DXL) improving potency of existing antibody products while opening new markets and disease applications. DXL antibodies utilize unique, novel and patented methods and technologies of InNexus. InNexus is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of The Mayo Clinic and has its own in-house developmental facilities. These development facilities provide validation of protein and peptide discoveries, enabling InNexus ( and its strategic partners) to advance novel drug therapeutics and diagnostics. To learn more about InNexus, please visit www.innexusbiotech.com. 
  *Mineral Exploration/Development  (not available) 
  *Change of Business/Reverse Takeover under review  Gold and Silver mine, Acquisition of Public Media Works of Delaware, under review. 
  *Gold And Silver Mining  (not available) 
Secondary  *Oil & Gas Extraction  (not available) 
  *Oil & Gas Exploration  (not available) 
Securities
SymbolSecurity NameMarketStatus
*IXS.H*InNexus Biotechnology Inc.TSX VentureDELIST
*IXS*InNexus Biotechnology Inc.TSX VentureDELIST
*CUS*Cusil Venture CorporationTSX VentureDELIST
*CUS*Cusil Venture CorporationVSEDELIST
Name HistoryFromTo
*InNexus Biotechnology Inc.3/Jul/20032/Oct/2013
*Cusil Venture Corporation5/Sep/19972/Jul/2003
Company Facts Reconciliation
SubjectDate Returned
Summer 2013 CFR29/Jul/2013
Associations
Auditing Firm:  *Hein & Associates, LLP, CPA
  *KPMG LLP
  *G. Ross McDonald, CA
Investor Relations:  *The Investor Relations Group Ltd.
Law Firm:  *Leschert & Company Law Corporation
  *Greg Yanke Law Corp.
  *Heenan Blaikie
Subsidiary:  *Innexus Inc.
  *Innexus Biotechnology International Ltd.
  *Innexus Exchange Corp.
  *North BioScience Inc.
  *Innexus Bioscience (Barbados) Inc.
Transfer Agent:  *Computershare Trust Company of Canada
Latest Information
TypeDateTitle
News Releases  7/Nov/2011  NEWS RELEASE - BCSC CEASE TRADE ORDER FOR ALDA PHARMACEUTICALS[MARKET NEWS]
    NEWS RELEASE - INNEXUS APPOINTS CHIEF FINANCIAL OFFICER[BUSINESS WIRE]
    NEWS RELEASE - INNEXUS GRANTS INCENTIVE STOCK OPTIONS[BUSINESS WIRE]
Bulletins  1/Oct/2013  Listing Maintenance Fees - Delist
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
Location Name: *Gord S Property Area Name: *Nicola Mining Division 
Effective Date: 22/Jun/2000 Location Ownership Percent: 100 
Expiry Date: 21/Sep/2004 Phone: (not available)
Address: British Columbia
Canada
North America
Fax: (not available)
Description:  
Location Name: *Knobhill Area Area Name: *Knobhill Area 
Effective Date: 22/Nov/1999 Location Ownership Percent:
Expiry Date: 31/Dec/2002 Phone: (not available)
Address: Alberta
Canada
North America
Fax: (not available)
Description:  
Location Name: *Merico Ethel Property Area Name: *James and Tudehope Townships 
Effective Date: 1/Oct/1997 Location Ownership Percent: 100 
Expiry Date: 1/Jun/1999 Phone: (not available)
Address: Ontario
Canada
North America
Fax: (not available)
Description: option to acquire, and subject to a 3% NSR 
Location Name: *Silver Fox Property Area Name: * 
Effective Date: 6/Jul/1998 Location Ownership Percent: 100 
Expiry Date: 1/Feb/1999 Phone: (not available)
Address: Ontario
Canada
North America
Fax: (not available)
Description: option to acquire, subject to a 2.5% NSR 

* Historical Data